New Canaan, CT, United States of America

Herbert F Oettgen

This inventor holds 20 USPTO granted patents, primarily in Monoclonal Antibodies. Top assignees: Sloan-Kettering Institute for Cancer Research, Sloan-Kettering Institute. Active years: 1985-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Herbert F Oettgen. Retrieved from https://idiyas.com/inventor/herbert-f-oettgen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20

% Patents Active = 100.0

Average Co-Inventor Count = 6.4

ph-index = 12

Forward Citations = 316(Granted Patents)

Location History:

New Canon, CT (US) (1991)
New Canaan, CT (US) (1985 - 1997)

Company Filing History:

19 out of 519

Sloan-Kettering Institute for Cancer Research

patents

1 out of 11

Sloan-Kettering Institute

patents

Years Active: 1985-1997

Loading Chart...

Areas of Expertise:

Colorectal Carcinoma

Melanoma

Monoclonal Antibodies

Antibody Panels

Human Sarcomas

Cytokeratin

Gastrointestinal Cancers

Renal Cancer

Tumor Antigens

Antibody Production

Cancer Cells

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5643550 - Method of treating colorectal carcinoma lesion and composition for use (1997-07-01),

2. 5431897 - Method of imaging colorectal carcinoma lesion and composition for use (1995-07-11),

3. 5160723 - Method of imaging colorectal carcinoma lesion and composition for use (1992-11-03),

4. 5102663 - Vaccine for stimulating or enhancing production of antibodies against (1992-04-07),

5. 5059523 - Cell-surface glycoproteins of human sarcomas (1991-10-22),

6. 5006470 - Human monoclonal antibodies to cell surface antigens of melanoma (1991-04-09),

7. 4935344 - Method for characterizing types of renal carcinoma and prognosis (1990-06-19),

8. 4865998 - Monoclonal antibodies to human lung cancers and method (1989-09-12),

9. 4851332 - Choriocarcinoma monoclonal antibodies and antibody panels (1989-07-25),

10. 4808704 - Monoclonal antibodies to cell surface antigens of human malignant (1989-02-28),

11. 4762800 - Monoclonal antibodies to cell surface antigens of human teratocarcinomas (1988-08-09),

12. 4727021 - Human monoclonal antibodies to cytokeratin (1988-02-23),

13. 4695538 - Human monoclonal antibodies to cell surface antigens (1987-09-22),

14. 4693966 - Human monoclonal antibodies from lymphocytes of patients with malignant (1987-09-15),

15. 4678747 - Monoclonal antibodies for detection of an H (O) blood group antigen (1987-07-07),

Title: The Innovative Journey of Herbert F. Oettgen

Introduction: Herbert F. Oettgen, a pioneering inventor based in New Canaan, CT (US), has made significant contributions to the world of innovations and patents with his groundbreaking ideas and creations.

Latest Patents: Herbert F. Oettgen holds several patents in various fields, including technology, healthcare, and engineering. His recent patents focus on advancements in renewable energy solutions and sustainable materials.

Career Highlights: Throughout his illustrious career, Herbert F. Oettgen has been recognized for his inventive spirit and problem-solving abilities. He has received numerous awards for his innovative contributions to society and has been a driving force behind several successful projects.

Collaborations: Herbert F. Oettgen has collaborated with leading research institutions, universities, and companies to bring his ideas to life. His partnerships have resulted in the development of cutting-edge technologies that have had a lasting impact on various industries.

Conclusion: In conclusion, Herbert F. Oettgen's passion for innovation and his dedication to pushing the boundaries of what is possible have solidified his reputation as a visionary inventor. His work continues to inspire future generations of inventors to think outside the box and create a better world through groundbreaking inventions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]